Article Versions Notes

Fiorillo A, Gallego JJ, Casanova-Ferrer F, Urios A, Ballester M-P, San Miguel T, Megías J, Kosenko E, Tosca J, Rios M-P, et al. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients. International Journal of Molecular Sciences. 2023; 24(19):14727. https://doi.org/10.3390/ijms241914727

Fiorillo, Alessandra, Juan José Gallego, Franc Casanova-Ferrer, Amparo Urios, María-Pilar Ballester, Teresa San Miguel, Javier Megías, Elena Kosenko, Joan Tosca, Maria-Pilar Rios, and et al. 2023. "Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients" International Journal of Molecular Sciences 24, no. 19: 14727. https://doi.org/10.3390/ijms241914727

Fiorillo, A., Gallego, J. J., Casanova-Ferrer, F., Urios, A., Ballester, M.-P., San Miguel, T., Megías, J., Kosenko, E., Tosca, J., Rios, M.-P., Escudero-García, D., & Montoliu, C. (2023). Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients. International Journal of Molecular Sciences, 24(19), 14727. https://doi.org/10.3390/ijms241914727